Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Inventory (2022 - 2025)

Historic Change in Inventory for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$8737.0.

  • bioAffinity Technologies' Change in Inventory fell 9834.28% to -$8737.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9871.0, marking a year-over-year decrease of 3613.07%. This contributed to the annual value of $9124.0 for FY2024, which is 2951.17% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Change in Inventory is -$8737.0, which was down 9834.28% from $5189.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Change in Inventory peaked at $20281.0 during Q2 2024, and registered a low of -$8997.0 during Q1 2024.
  • Over the past 4 years, bioAffinity Technologies' median Change in Inventory value was $58.0 (recorded in 2022), while the average stood at $2348.9.
  • In the last 5 years, bioAffinity Technologies' Change in Inventory skyrocketed by 500057.14% in 2023 and then tumbled by 218238.34% in 2024.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Change in Inventory stood at -$175.0 in 2022, then soared by 5000.57% to $8576.0 in 2023, then tumbled by 73.82% to $2245.0 in 2024, then plummeted by 489.18% to -$8737.0 in 2025.
  • Its Change in Inventory was -$8737.0 in Q3 2025, compared to $5189.0 in Q2 2025 and $11174.0 in Q1 2025.